SCHEMBL14498063

CC(C)C[C@H](NC(=O)[C@@H](C)Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N(C)[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C

nearest known ligand 0.63

Predicted protein targets (top 2)

	gene	UniProt	supporting neighbours	confidence
▸	IL23R	Q5VWK5	7/20	0.63

▸	KISS1R	Q969F8	13/20	0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL14498068	0.96	KISS1R (0.65)	IL23RKISS1R
SCHEMBL12417315	0.96	KISS1R (0.65)	IL23RKISS1R
SCHEMBL13248723	0.96	KISS1R (0.65)	IL23RKISS1R
SCHEMBL13248747	0.93	IL23R (0.66)	IL23RKISS1R
SCHEMBL12417333	0.93	IL23R (0.66)	IL23RKISS1R
SCHEMBL12508010	0.93	IL23R (0.66)	IL23RKISS1R
SCHEMBL12417309	0.93	IL23R (0.64)	IL23RKISS1R
SCHEMBL14498050	0.93	IL23R (0.64)	IL23RKISS1R
SCHEMBL7738071	0.92	IL23R (0.66)	IL23RKISS1R
SCHEMBL12508017	0.92	IL23R (0.66)	IL23RKISS1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20070135351-A1	Neuropeptide-2 receptor (Y-2R) agonists and uses thereof	CONDE-KNAPE KARIN	2007-06-14	—	—	US	disclosed
US-20070135351-A1	Neuropeptide-2 receptor (Y-2R) agonists and uses thereof	CONDE-KNAPE KARIN	2007-06-14	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20070135351-A1	Neuropeptide-2 receptor (Y-2R) agonists and uses thereof	NPY2R, NPY1R, NPY4R	IL23R 549/4885KISS1R 131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.